These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11960210)

  • 41. Clonal analysis by chromosome 11 microsatellite-PCR of microdissected parathyroid tumors from MEN 1 patients.
    Morelli A; Falchetti A; Amorosi A; Tonelli F; Bearzi I; Ranaldi R; Tomassetti P; Brandi ML
    Biochem Biophys Res Commun; 1996 Oct; 227(3):736-42. PubMed ID: 8886003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
    Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
    Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung.
    Debelenko LV; Brambilla E; Agarwal SK; Swalwell JI; Kester MB; Lubensky IA; Zhuang Z; Guru SC; Manickam P; Olufemi SE; Chandrasekharappa SC; Crabtree JS; Kim YS; Heppner C; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Collins FS; Travis WD; Emmert-Buck MR
    Hum Mol Genet; 1997 Dec; 6(13):2285-90. PubMed ID: 9361035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Endocrine tumors of the pancreas. Review of 30 years of research].
    Bordi C
    Pathologica; 1998 Jun; 90(3):215-21. PubMed ID: 9774858
    [No Abstract]   [Full Text] [Related]  

  • 46. CpG island methylation in carcinoid and pancreatic endocrine tumors.
    Chan AO; Kim SG; Bedeir A; Issa JP; Hamilton SR; Rashid A
    Oncogene; 2003 Feb; 22(6):924-34. PubMed ID: 12584572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.
    Larsson C; Skogseid B; Oberg K; Nakamura Y; Nordenskjöld M
    Nature; 1988 Mar; 332(6159):85-7. PubMed ID: 2894610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
    Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identical clonality of sporadic gastrinomas at multiple sites.
    Goebel SU; Vortmeyer AO; Zhuang Z; Serrano J; Jensen RT; Lubensky IA
    Cancer Res; 2000 Jan; 60(1):60-3. PubMed ID: 10646853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
    Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
    Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of p53 tumor suppressor gene in pancreatic endocrine tumors of Chinese patients.
    Lam KY; Lo CY
    Am J Gastroenterol; 1998 Aug; 93(8):1232-5. PubMed ID: 9707043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of the Sm-like proto-oncogene in primary and metastatic pancreatic endocrine tumors.
    Gumbs AA; Bassi C; Moore PS; Falconi M; Frigerio I; Baron A; Piemonti L; Modlin I; Scarpa A
    JOP; 2002 Jul; 3(4):109-15. PubMed ID: 12110768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Gastrin cell hyperplasia associated with duodenal MEN1-related gastrinomas: histopathology and genetics].
    Anlauf M; Perren A; Klöppel G
    Verh Dtsch Ges Pathol; 2007; 91():320-9. PubMed ID: 18314630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
    Välimäki S; Forsberg L; Farnebo LO; Larsson C
    Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survey of genetic alterations in gastrinomas.
    Yu F; Jensen RT; Lubensky IA; Mahlamaki EH; Zheng YL; Herr AM; Ferrin LJ
    Cancer Res; 2000 Oct; 60(19):5536-42. PubMed ID: 11034099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
    Miyaki M; Yamaguchi T; Iijima T; Funata N; Mori T
    Oncology; 2006; 71(1-2):131-5. PubMed ID: 17347589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
    Görtz B; Roth J; Krähenmann A; de Krijger RR; Muletta-Feurer S; Rütimann K; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
    Am J Pathol; 1999 Feb; 154(2):429-36. PubMed ID: 10027401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telomerase activity in pancreatic endocrine tumors.
    Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
    Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.
    Dong Q; Debelenko LV; Chandrasekharappa SC; Emmert-Buck MR; Zhuang Z; Guru SC; Manickam P; Skarulis M; Lubensky IA; Liotta LA; Collins FS; Marx SJ; Spiegel AM
    J Clin Endocrinol Metab; 1997 May; 82(5):1416-20. PubMed ID: 9141526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.